Accounts Receivable, after Allowance for Credit Loss, Current in USD of Emeren Group Ltd from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Emeren Group Ltd quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2010 to Q3 2025.
  • Emeren Group Ltd Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending September 30, 2025 was $16M, a 34.6% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)

Emeren Group Ltd Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $16M -$8.44M -34.6% Sep 30, 2025 10-Q 2025-11-14
Q2 2025 $16.5M -$6.68M -28.8% Jun 30, 2025 10-Q 2025-08-19
Q1 2025 $20.8M -$5.75M -21.7% Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $21.1M -$6M -22.1% Dec 31, 2024 10-Q 2025-11-14
Q3 2024 $24.4M Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $23.2M Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $26.5M Mar 31, 2024 10-Q 2024-08-19
Q4 2023 $27.1M +$5.42M +25% Dec 31, 2023 10-K 2025-03-25
Q4 2022 $21.7M -$12.6M -36.7% Dec 31, 2022 10-Q 2024-11-14
Q4 2021 $34.3M +$14.1M +69.9% Dec 31, 2021 10-K 2024-08-01
Q4 2020 $20.2M +$6.35M +45.9% Dec 31, 2020 20-F/A 2022-08-23
Q4 2019 $13.8M -$20.6M -59.9% Dec 31, 2019 20-F 2021-04-28
Q4 2018 $34.5M +$11.2M +47.9% Dec 31, 2018 20-F 2020-04-28
Q4 2017 $23.3M +$23.2M +27023% Dec 31, 2017 20-F 2019-04-29
Q4 2016 $85.9K -$117M -99.9% Dec 31, 2016 20-F 2018-04-30
Q4 2015 $118M +$5.55M +4.95% Dec 31, 2015 20-F 2017-04-28
Q2 2015 $89.8M -$123M -57.7% Jun 30, 2015 6-K 2015-09-30
Q4 2014 $112M -$125M -52.7% Dec 31, 2014 20-F 2016-04-28
Q2 2014 $213M -$59.6M -21.9% Jun 30, 2014 6-K 2014-09-19
Q4 2013 $237M +$19.7M +9.1% Dec 31, 2013 20-F 2015-04-23
Q2 2013 $272M Jun 30, 2013 6-K 2013-12-05
Q4 2012 $217M +$87.2M +67.3% Dec 31, 2012 20-F 2014-04-25
Q4 2011 $130M +$48.1M +59% Dec 31, 2011 20-F 2013-04-26
Q4 2010 $81.5M Dec 31, 2010 20-F/A 2012-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.